• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchiBio
    Picture of iBio logo

    IBIO — iBio News Story

    $0.720.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapSucker Stock
    • Market Cap
      $46.16m
    • Enterprise Value
      -$41.88m
    • Revenue
      $0.10m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • IBIO Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    IBIO Dividends
    All News

    NASDAQ RESUMED AT 09:43 AM

    Picture of iBio logoiBio
    08/12/2025 14:43
    NASDAQ RESUMED  IBIO.O  AT 09:43 AM
    

    Recent news on iBio

    See all news
    • Brief: iBio - IBIO-610 Plus Semaglutide Preserves Lean Mass In Eight-Week Obese NHP Study

      13/10/2026 13:09
    • Brief: Ibio Reports Fiscal Year 2026 Financial Results And Provides Corporate Update

      28/08/2026 13:12
    • Brief: Ibio Reports Q3 Fiscal Year 2026 Financial Results And Provides Corporate Update

      12/05/2026 22:43
    • U.S. STOCKS ON THE MOVE-Meta, Legence, Chegg

      08/04/2026 19:10
    • U.S. STOCKS ON THE MOVE-Hims & Hers, Chewy, Longeveron

      08/04/2026 16:51

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.